Su Wei, Lai Houhua, Tang Xin, Zhou Qun, Tang Yachun, Fu Hao, Chen Xuancai
Department of Urology, Affiliated Nanhua Hospital of Nanhua University, Hengyang 421001, China.
Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510260, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jun 20;45(6):1289-1296. doi: 10.12122/j.issn.1673-4254.2025.06.18.
To investigate the role of apelin in regulating proliferation, migration and angiogenesis of bladder cancer cells and the possible regulatory mechanism.
GEO database was used to screen the differentially expressed genes in bladder cancer tissues and cells. Bladder cancer and paired adjacent tissues were collected from 60 patients for analysis of apelin expressions in relation to clinicopathological parameters. In cultured bladder cancer J82 cells and human umbilical vein endothelial cells (HUVECs), the effects of transfection with an apelin-overexpressing plasmid or specific siRNAs targeting apelin, fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 1 (FGFR1) on proliferation and migration of J82 cells and tube formation in HUVECs were examined using plate cloning assay, Transwell assay, and angiogenesis assay; the changes in FGF2 expression and FGFR1 phosphorylation were detected using Western blotting.
The expression level of apelin was significantly higher in bladder cancer tissues than adjacent tissues, and bladder cancer cell lines (T24 and J82) also expressed higher mRNA and protein levels of apelin than SV-HUC-1 cells. Apelin expression level in bladder cancer tissues was correlated with tumor invasion, distant metastasis and advanced TNM stages. Apelin knockdown significantly suppressed proliferation and migration of J82 cells and decreased the total angiogenic length of HUVECs. In contrast, apelin overexpression significantly promoted proliferation and migration and enhanced FGFR1 phosphorylation in J82 cells, and increased the total angiogenesis length in HUVECs, but this effects were effectively mitigated by transfection of the cells with FGF2 siRNA or FGFR1 siRNA.
High expression of apelin promotes J82 cell proliferation and migration and HUVEC angiogenesis by promoting activation of the FGF2/FGFR1 pathway.
探讨apelin在调节膀胱癌细胞增殖、迁移和血管生成中的作用及其可能的调控机制。
利用GEO数据库筛选膀胱癌组织和细胞中的差异表达基因。收集60例患者的膀胱癌组织及配对的癌旁组织,分析apelin表达与临床病理参数的关系。在培养的膀胱癌J82细胞和人脐静脉内皮细胞(HUVECs)中,采用平板克隆实验、Transwell实验和血管生成实验检测转染apelin过表达质粒或靶向apelin、成纤维细胞生长因子2(FGF2)和成纤维细胞生长因子受体1(FGFR1)的特异性siRNA对J82细胞增殖和迁移以及HUVECs管腔形成的影响;采用蛋白质免疫印迹法检测FGF2表达和FGFR1磷酸化的变化。
膀胱癌组织中apelin的表达水平显著高于癌旁组织,膀胱癌细胞系(T24和J82)中apelin的mRNA和蛋白水平也高于SV-HUC-1细胞。膀胱癌组织中apelin的表达水平与肿瘤侵袭、远处转移及TNM分期相关。敲低apelin可显著抑制J82细胞的增殖和迁移,并降低HUVECs的总血管生成长度。相反,apelin过表达显著促进J82细胞的增殖和迁移,增强FGFR1磷酸化,并增加HUVECs的总血管生成长度,但用FGF2 siRNA或FGFR1 siRNA转染细胞可有效减轻这种作用。
apelin的高表达通过促进FGF2/FGFR1途径的激活来促进J82细胞增殖、迁移及HUVECs血管生成。